TPS04--Lungs & Beyond

Chair(s)

• 

  Kadambari Vijaykumar, MD

  University of Alabama-Birmingham
• 

  Milene Saavedra, Denver, USA

  Medicine
  National Jewish Health

Presentations:

• 10:15 AM - 11:45 AM PDT

  Impact of highly effective modulator therapy on chronic rhinosinusitis and olfactory dysfunction: 4-year outcomes
  

  Speaker: Jessa E. Miller, MD – University of Michigan Medical School
• 10:15 AM - 11:45 AM PDT

  Decreased elexacaftor/tezacaftor/ivacaftor concentrations during pregnancy: the MAYFLOWERS PK Sub-study
  

  Speaker: Charles R. Esther, Jr., MD, PhD – Univ of North Carolina Chapel
• 10:15 AM - 11:45 AM PDT

  Pancreatic cancer risk in adults living longer with CF: Early insights from an MRCP-based screening protocol
  

  Speaker: Ahmet Uluer, DO, MPH – Brigham and Women's Hospital and Boston Children's Hospital
• 10:15 AM - 11:45 AM PDT

  The power of breath: An innovative diagnostic for P. aeruginosa cystic fibrosis lung infections
  

  Speaker: Trenton J. Davis, Ph.D. – Arizona State University
• 10:15 AM - 11:45 AM PDT

  Impact of elexacaftor, tezacaftor and ivacaftor on hepatic status after 4-5 years: Results of the combined PROMISE and RECOVER studies.
  

  Speaker: Michael R. Narkewicz, MD – University of Colorado SOM and Children's Hospital Colorado
• 10:15 AM - 11:45 AM PDT

  Proteomic analysis of exhaled breath condensate to identify protein signatures of infection in people with cystic fibrosis
  

  Speaker: Michael Kim, PhD – University of Kansas Medical Center
• 10:15 AM - 11:45 AM PDT

  Outcomes in first year of life for infants with exposure to elexacaftor/tezacaftor/ivacaftor (ETI) in utero
  

  Speaker: Deanna Green – Johns Hopkins All Children's Hospital
• 10:15 AM - 11:45 AM PDT

  CForwaRD: Personalized CFRD risk assessment looking ahead 1, 2, and 5 years after the most recent OGTT.
  

  Speaker: Malinda Wu, MD, MSCR – Johns Hopkins University School of Medicine
• 10:15 AM - 11:45 AM PDT

  The role and impact of antifungals in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis
  

  Speaker: Gina Hong, MD, MHS – University of Pennsylvania Perelman School of Medicine